-
1
-
-
3042567016
-
Long-term donepezil treatment in 565 patients with Alzheimer's disease (AD2000): Randomised double-blind trial
-
AD2000 Collaborative Group
-
AD2000 Collaborative Group. (2004) Long-term donepezil treatment in 565 patients with Alzheimer's disease (AD2000): randomised double-blind trial. The Lancet, 363, 2105-2115.
-
(2004)
The Lancet
, vol.363
, pp. 2105-2115
-
-
-
2
-
-
77956077677
-
-
Alzheimer's Society, Retrieved December 19, from
-
Alzheimer's Society (2006). Access to drugs. Retrieved December 19, 2006, from http://www.alzheimers.org.uk/News_and_Campaigns/Campaigning/accesstodrugs.htm.
-
(2006)
Access to Drugs
-
-
-
3
-
-
77950143856
-
Success and challenges in using focus groups with older people with dementia
-
In H. Wilkinson (Ed.), London: Jessica Kingsley
-
Bamford, C., & Bruce, E. (2002). Success and challenges in using focus groups with older people with dementia. In H. Wilkinson (Ed.), The perspectives of people with dementia: Research methods and motivations (pp. 139-164). London: Jessica Kingsley.
-
(2002)
The Perspectives of People with Dementia: Research Methods and Motivations
, pp. 139-164
-
-
Bamford, C.1
Bruce, E.2
-
4
-
-
34447268978
-
Can primary care record review facilitate earlier diagnosis of demenita?
-
Bamford, C., Eccles, M., Steen, N., & Robinson, L. (2007). Can primary care record review facilitate earlier diagnosis of demenita?. Family Practice, 24, 108-116.
-
(2007)
Family Practice
, vol.24
, pp. 108-116
-
-
Bamford, C.1
Eccles, M.2
Steen, N.3
Robinson, L.4
-
5
-
-
1342326703
-
Disclosing a diagnosis of dementia: A systematic review
-
Bamford, C., Lamont, S., Eccles, M., Robinson, L., May, C., & Bond, J. (2004). Disclosing a diagnosis of dementia: a systematic review. International Journal of Geriatric Psychiatry, 19, 151-169.
-
(2004)
International Journal of Geriatric Psychiatry
, vol.19
, pp. 151-169
-
-
Bamford, C.1
Lamont, S.2
Eccles, M.3
Robinson, L.4
May, C.5
Bond, J.6
-
7
-
-
70349119559
-
Rivastigmine for Alzheimer's disease
-
Issue, John Wiley & Sons Ltd
-
Birks, J., Grimley Evans, J., Iakovidou, V., & Tsolaki, M. (2004). Rivastigmine for Alzheimer's disease. Cochrane Review. The Cochrane Library, 2004, Issue 1. John Wiley & Sons Ltd.
-
(2004)
Cochrane Review. The Cochrane Library
, vol.1
-
-
Birks, J.1
Grimley, E.J.2
Iakovidou, V.3
Tsolaki, M.4
-
8
-
-
37649026816
-
Donepezil for dementia due to Alzheimer's disease
-
Issue, John Wiley & Sons Ltd
-
Birks, J.S., & Harvey, R. (2004). Donepezil for dementia due to Alzheimer's disease. Cochrane Review. The Cochrane Library, 2004, Issue 1. John Wiley & Sons Ltd.
-
(2004)
Cochrane Review. The Cochrane Library
, vol.1
-
-
Birks, J.S.1
Harvey, R.2
-
9
-
-
0036622723
-
Clinical and costeffectiveness of donepezil, rivastigmine, and galantamine for Alzheimer's disease: A systematic review
-
Clegg, A., Bryant, J., Nicholson, T., McIntyre, L., de Broe, S., & Gerard, K. (2002). Clinical and costeffectiveness of donepezil, rivastigmine, and galantamine for Alzheimer's disease: a systematic review. International Journal of Technology Assessment in Health Care, 18(3), 497-507.
-
(2002)
International Journal of Technology Assessment in Health Care
, vol.18
, Issue.3
, pp. 497-507
-
-
Clegg, A.1
Bryant, J.2
Nicholson, T.3
McIntyre, L.4
de Broe, S.5
Gerard, K.6
-
12
-
-
0016823810
-
Mini-mental state: A practical method for grading the cognitive state of patients for the clinician
-
Folstein, M.F., Folstein, S.E., & McHugh, P.R. (1975). Mini-mental state: A practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research, 12, 189-198.
-
(1975)
Journal of Psychiatric Research
, vol.12
, pp. 189-198
-
-
Folstein, M.F.1
Folstein, S.E.2
McHugh, P.R.3
-
13
-
-
77956087731
-
Improvements in functional ability with galantamine in Alzheimer's have not yet been established [Rapid response letter]
-
Gray, R. (2001). Improvements in functional ability with galantamine in Alzheimer's have not yet been established [Rapid response letter]. British Medical Journal, 321(7274), 1445.
-
(2001)
British Medical Journal
, vol.321
, Issue.7274
, pp. 1445
-
-
Gray, R.1
-
14
-
-
0015241782
-
The inverse care law
-
Hart, J.T. (1971). The inverse care law. The Lancet, 1(7696), 405-412.
-
(1971)
The Lancet
, vol.1
, Issue.7696
, pp. 405-412
-
-
Hart, J.T.1
-
15
-
-
34547837414
-
NICE vindicated in UK's high court
-
Horton, R. (2007). NICE vindicated in UK's high court. The Lancet, 370(9587), 547-548.
-
(2007)
The Lancet
, vol.370
, Issue.9587
, pp. 547-548
-
-
Horton, R.1
-
16
-
-
4043084833
-
Dementia, postcode prescribing and NICE
-
Jones, R.W. (2004). Dementia, postcode prescribing and NICE. Age and Ageing, 33(4), 331-332.
-
(2004)
Age and Ageing
, vol.33
, Issue.4
, pp. 331-332
-
-
Jones, R.W.1
-
17
-
-
34249691316
-
Commentary on 'Health economics and the value of therapy in Alzheimer's disease'. Drug treatment of Alzheimer's disease: The United Kingdom experience - National Institute for Health and Clinical Excellence guidance and guidelines for dementia
-
Jones, R.W. (2007). Commentary on 'Health economics and the value of therapy in Alzheimer's disease'. Drug treatment of Alzheimer's disease: The United Kingdom experience - National Institute for Health and Clinical Excellence guidance and guidelines for dementia. Alzheimer's & Dementia, 3(3), 180-185.
-
(2007)
Alzheimer's & Dementia
, vol.3
, Issue.3
, pp. 180-185
-
-
Jones, R.W.1
-
18
-
-
0035677785
-
Acetylcholinesterase treatment - modelling potential demand and auditing practice
-
Lovestone, S., & Murray, D. (2001). Acetylcholinesterase treatment - modelling potential demand and auditing practice. International Journal of Geriatric Psychiatry, 16, 1136-1142.
-
(2001)
International Journal of Geriatric Psychiatry
, vol.16
, pp. 1136-1142
-
-
Lovestone, S.1
Murray, D.2
-
19
-
-
0037048967
-
Adherence to NICE guidance for the use of anticholinesterases for Alzheimer's disease
-
Mace, S., & Taylor, D. (2002). Adherence to NICE guidance for the use of anticholinesterases for Alzheimer's disease. Pharmaceutical Journal, 269, 680-681.
-
(2002)
Pharmaceutical Journal
, vol.269
, pp. 680-681
-
-
Mace, S.1
Taylor, D.2
-
20
-
-
85007768150
-
Science, medicine and the future: Alzheimer's disease
-
Masters, C.L., & Beyreuther, K. (1998). Science, medicine and the future: Alzheimer's disease. British Medical Journal, 316, 446-448.
-
(1998)
British Medical Journal
, vol.316
, pp. 446-448
-
-
Masters, C.L.1
Beyreuther, K.2
-
21
-
-
34547534966
-
Reaching the population with dementia drugs: What are the challenges?
-
Matthews, F.E., McKeith, I., Bond, J., & Brayne, C. (2006). Reaching the population with dementia drugs: what are the challenges?. International Journal of Geriatric Psychiatry, 22(7), 627-631.
-
(2006)
International Journal of Geriatric Psychiatry
, vol.22
, Issue.7
, pp. 627-631
-
-
Matthews, F.E.1
McKeith, I.2
Bond, J.3
Brayne, C.4
-
23
-
-
0034856130
-
Costs of dementia in England and Wales in the 21st century
-
the Resource Implications Study of the Medical Research Council Cognitive Function and Ageing Study
-
McNamee, P., Bond, J., & Buck, D. & the Resource Implications Study of the Medical Research Council Cognitive Function and Ageing Study (2001). Costs of dementia in England and Wales in the 21st century. British Journal of Psychiatry, 179, 261-266.
-
(2001)
British Journal of Psychiatry
, vol.179
, pp. 261-266
-
-
McNamee, P.1
Bond, J.2
Buck, D.3
-
24
-
-
0032492253
-
New drug treatment for Alzheimer's disease: Lessons for healthcare policy
-
Melzer, D. (1998). New drug treatment for Alzheimer's disease: lessons for healthcare policy. British Medical Journal, 316, 762-764.
-
(1998)
British Medical Journal
, vol.316
, pp. 762-764
-
-
Melzer, D.1
-
29
-
-
77956085867
-
-
National Institute for Health and Clinical Excellence.,. Retrieved 23 April, from, london: National Institute for Health and Clinical Excellence
-
National Institute for Health and Clinical Excellence. (2007). Outcome of judicial review for NICE guidance on drugs for Alzheimer's Disease. london: National Institute for Health and Clinical Excellence. Retrieved 23 April, 2008 from http://www.nice.org.uk/newsevents/infocus/infocusarchive/OutcomeofJR.jsp.
-
(2007)
Outcome of Judicial Review for NICE Guidance on Drugs for Alzheimer's Disease
-
-
-
31
-
-
0001457476
-
Qualitative data analysis for applied policy research
-
In A. Bryman, & R. G. Burgess (Eds.), London & New York: Routledge
-
Ritchie, J., & Spencer, L. (1994). Qualitative data analysis for applied policy research. In A. Bryman, & R. G. Burgess (Eds.), Analyzing qualitative data (pp. 173-194). London & New York: Routledge.
-
(1994)
Analyzing Qualitative Data
, pp. 173-194
-
-
Ritchie, J.1
Spencer, L.2
-
32
-
-
3042658322
-
AD2000: Donepezil in Alzheimer's disease
-
Schneider, L.S. (2004). AD2000: donepezil in Alzheimer's disease. The Lancet, 363, 2100-2101.
-
(2004)
The Lancet
, vol.363
, pp. 2100-2101
-
-
Schneider, L.S.1
-
34
-
-
8444248351
-
What's the evidence that NICE guidance has been implemented? Results from a national evaluation using time series analysis, audit of patients' notes, and interviews
-
Sheldon, T.A., Cullum, N., Dawson, D., Lankshear, A., Lowson, K., & Watt, I. (2004). What's the evidence that NICE guidance has been implemented? Results from a national evaluation using time series analysis, audit of patients' notes, and interviews. BMJ, 329(7473), 999-1003.
-
(2004)
BMJ
, vol.329
, Issue.7473
, pp. 999-1003
-
-
Sheldon, T.A.1
Cullum, N.2
Dawson, D.3
Lankshear, A.4
Lowson, K.5
Watt, I.6
|